Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,715 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants.
Li Y, Zhang H, Pandya H, Miao L, Reid F, Jimenez E, Sadiq MW, Moate R, Lei A, Zhou XH, Kell C, Ding J, Zhang G, Zhao L, Ge X. Li Y, et al. Among authors: ge x. Clin Pharmacol Drug Dev. 2024 Mar 25. doi: 10.1002/cpdd.1391. Online ahead of print. Clin Pharmacol Drug Dev. 2024. PMID: 38523487
Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.
Cheung TT, Mai TH, Chia YL, Yap DYH, Lee CH, Chen CC, Huang Y, Jin Y, Johnston J, Werkström V, Yao Y, Ge X, Zheng W. Cheung TT, et al. Among authors: ge x. Drug Des Devel Ther. 2023 Jan 26;17:209-218. doi: 10.2147/DDDT.S392155. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 36726737 Free PMC article. Clinical Trial.
Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: The primary analysis of a phase 1 open-label study.
Wang Z, Zhang X, Li C, Liu Y, Ge X, Zhao J, Yuan X, Li Q. Wang Z, et al. Among authors: ge x. Clin Transl Med. 2024 Mar;14(3):e1589. doi: 10.1002/ctm2.1589. Clin Transl Med. 2024. PMID: 38456222 Free PMC article. Clinical Trial. No abstract available.
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2.
Jia Z, Wang K, Xie M, Wu J, Hu Y, Zhou Y, Yisimayi A, Fu W, Wang L, Liu P, Fan K, Chen R, Wang L, Li J, Wang Y, Ge X, Zhang Q, Wu J, Wang N, Wu W, Gao Y, Miao J, Jiang Y, Qin L, Zhu L, Huang W, Zhang Y, Zhang H, Li B, Gao Q, Xie XS, Wang Y, Cao Y, Wang Q, Wang X. Jia Z, et al. Among authors: ge x. Protein Cell. 2024 May 27:pwae033. doi: 10.1093/procel/pwae033. Online ahead of print. Protein Cell. 2024. PMID: 38801319 Free article. No abstract available.
4,715 results